PERSPECTA

News from every angle

Back to headlines

TD Cowen Lifts Price Target on Regeneron Pharmaceuticals Ahead of Q1 Results

TD Cowen has increased its price target for Regeneron Pharmaceuticals, signaling optimism for the company's financial performance ahead of its fiscal first-quarter results.

27 Apr, 06:04 — 27 Apr, 06:04
PostShare

Sources

Showing 1 of 1 sources